a year ago
RXDX
AnalystsGregory RenzaGregory Renza's Stock Forecasts
AnalystsGregory Renza
Analyst Ranking
Top 6%
#241 out of 4670 analysts
Average Return
+12.44%
Win Rate
43%75 out of 175
Risk vs Reward
Poor
Good
Gregory Renza's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Prometheus Biosciences IncRXDX | +603.13% | $27.52 | $193.50 | 2022-05-13 - 2023-04-18 | Buy |
Alpine Immune Sciences IncALPN | +428.30% | $12.19 | $64.40 | 2023-10-05 - 2024-04-11 | Buy |
Adc Therapeutics SaADCT | +350.00% | $0.60 | $2.70 | 2023-11-08 - 2024-09-06 | Buy |
Nurix Therapeutics IncNRIX | +319.98% | $5.56 | $23.33 | 2023-11-02 - 2024-09-06 | Buy |
Alpine Immune Sciences IncALPN | +300.75% | $16.07 | $64.40 | 2023-11-03 - 2024-04-11 | Buy |
Gregory Renza Analyst Color
Get additional color on Gregory Renza's coverage of popular stocks
Gregory Renza's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bicycle Therapeutics PLCBCYC | 1 | Buy | $35.00 | +70.40% | Initiates Coverage On | 3 days ago |
Viridian Therapeutics IncVRDN | 7 | Buy | $35.00 | +148.40% | Reiterates | 12 days ago |
Perspective Therapeutics IncCATX | 3 | Buy | $27.00 | +76.93% | Maintains | 24 days ago |
Verrica Pharmaceuticals IncVRCA | 5 | Buy | $13.00 | +580.63% | Maintains | 25 days ago |
Viracta Therapeutics IncVIRX | 7 | Buy | $4.00 | +1,559.75% | Maintains | 25 days ago |
Cormedix IncCRMD | 4 | Buy | $9.00 | +56.25% | Reiterates | 25 days ago |
Atyr Pharma IncATYR | 6 | Buy | $16.00 | +751.06% | Reiterates | a month ago |
Jasper Therapeutics IncJSPR | 2 | Buy | $68.00 | +265.00% | Maintains | a month ago |
Spruce Biosciences IncSPRB | 10 | Hold | $2.00 | +346.43% | Reiterates | a month ago |
Pacira Biosciences IncPCRX | 8 | Hold | $14.00 | +1.08% | Downgrades | a month ago |
Verastem IncVSTM | 7 | Buy | $13.00 | +441.67% | Maintains | a month ago |
Inovio Pharmaceuticals IncINO | 7 | Hold | $8.00 | +27.39% | Maintains | a month ago |
Ideaya Biosciences IncIDYA | 10 | Buy | $61.00 | +68.46% | Reiterates | a month ago |
Exelixis IncEXEL | 4 | Buy | $27.00 | +7.36% | Reiterates | a month ago |
Acadia Pharmaceuticals IncACAD | 13 | Buy | $26.00 | +61.79% | Maintains | a month ago |
Adc Therapeutics SaADCT | 11 | Buy | $8.00 | +196.30% | Reiterates | a month ago |
Amgen IncAMGN | 13 | Buy | $362.00 | +12.93% | Maintains | a month ago |
Xencor IncXNCR | 7 | Buy | $31.00 | +91.59% | Reiterates | a month ago |
Nuvation Bio IncNUVB | 4 | Buy | $5.00 | +79.21% | Reiterates | a month ago |
Agios Pharmaceuticals IncAGIO | 3 | Buy | $55.00 | +27.08% | Maintains | a month ago |
Jazz Pharmaceuticals PLCJAZZ | 8 | Buy | $174.00 | +62.40% | Maintains | a month ago |
Morphic Holding IncMORF | 7 | Hold | $57.00 | +0.02% | Reiterates | a month ago |
Nurix Therapeutics IncNRIX | 9 | Buy | $27.00 | +15.73% | Maintains | 2 months ago |
Alpine Immune Sciences IncALPN | 4 | Hold | $65.00 | +0.05% | Downgrades | 5 months ago |
Fusion Pharmaceuticals IncFUSN | 3 | Hold | $21.00 | -2.55% | Downgrades | 6 months ago |
Fulcrum Therapeutics IncFULC | 1 | Buy | $14.00 | +63.93% | Initiates Coverage On | 6 months ago |
Aptose Biosciences IncAPTO | 7 | Buy | $18.00 | +4,858.68% | Maintains | 10 months ago |
Avalo Therapeutics IncAVTX | 4 | Hold | $180.00 | N/A | Downgrades | a year ago |
Bellus Health IncBLU | 8 | Hold | $14.75 | N/A | Reiterates | a year ago |
Prometheus Biosciences IncRXDX | 6 | Hold | $200.00 | N/A | Maintains | a year ago |
Seagen IncSGEN | 5 | Buy | $229.00 | N/A | Maintains | a year ago |
Global Blood Therapeutics IncGBT | 3 | Hold | $68.50 | N/A | Downgrades | 2 years ago |
Aprea Therapeutics IncAPRE | 5 | Hold | $80.00 | N/A | Maintains | 2 years ago |
Provention Bio IncPRVB | 2 | Hold | $10.00 | N/A | Downgrades | 3 years ago |
Iterum Therapeutics PLCITRM | 3 | Hold | $30.00 | N/A | Downgrades | 4 years ago |
Portola Pharmaceuticals IncPTLA | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 4 years ago |
Arqule IncARQL | 1 | Hold | $20.00 | N/A | Downgrades | 5 years ago |
Gamida Cell LtdGMDAQ | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.